FDA approves AI tool for spotting wrist fractures

The approval came relatively quickly by using the De Novo premarket review pathway, which streamlines the process for products with “low to moderate risk.” You may have to wait a while before you see OsteoDetect in use at the family doctor’s office. However, you might see considerably more AI going forward. FDA commissioner Scott Gottlieb …

Continue reading “FDA approves AI tool for spotting wrist fractures”